Drug-induced lung injury / Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba, Editors
Part I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
[2018] |
|---|---|
| Erschienen: |
Singapore: Springer ; 2018 |
| Reihe: |
Respiratory disease series: diagnostic tools and disease managements |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hanaoka, Masayuki [HerausgeberIn] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Nlm: |
WF 653 |
|---|---|
| Themen: |
Drug-Related Side Effects and Adverse Reactions |
| Umfang: |
1 Online-Ressource (VIII, 215 Seiten) ; Illustrationen |
|---|
| doi: |
10.1007/978-981-10-4466-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1656849003 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1656849003 | ||
| 003 | DE-627 | ||
| 005 | 20230427041229.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171106s2018 si |||||o 00| ||eng c | ||
| 020 | |a 9789811044663 |9 978-981-10-4466-3 | ||
| 024 | 7 | |a 10.1007/978-981-10-4466-3 |2 doi | |
| 035 | |a (DE-627)1656849003 | ||
| 035 | |a (DE-576)49503519X | ||
| 035 | |a (DE-599)BSZ49503519X | ||
| 035 | |a (OCoLC)1033810943 | ||
| 035 | |a (DE-He213)978-981-10-4466-3 | ||
| 035 | |a (EBP)04009071X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XB-SG | ||
| 050 | 0 | |a RC705-779 | |
| 060 | 0 | |a WF 653 | |
| 072 | 7 | |a MJL |2 bicssc | |
| 072 | 7 | |a MED079000 |2 bisacsh | |
| 245 | 1 | 0 | |a Drug-induced lung injury |c Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba, Editors |
| 264 | 1 | |a Singapore |b Springer |c [2018] | |
| 300 | |a 1 Online-Ressource (VIII, 215 Seiten) |b Illustrationen | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Respiratory disease series: diagnostic tools and disease managements | |
| 490 | 0 | |a SpringerLink |a Bücher | |
| 490 | 0 | |a Springer eBook Collection |a Medicine | |
| 520 | |a Part I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs? | ||
| 650 | 0 | |a Medicine | |
| 650 | 0 | |a Medicine & Public Health | |
| 650 | 0 | |a Respiratory organs |x Diseases | |
| 650 | 2 | |a Lung Injury |x chemically induced | |
| 650 | 2 | |a Lung Injury |x diagnosis | |
| 650 | 2 | |a Lung |x drug effects | |
| 650 | 2 | |a Drug-Related Side Effects and Adverse Reactions |x diagnosis | |
| 650 | 2 | |a Risk Factors | |
| 700 | 1 | |a Hanaoka, Masayuki |e herausgeberin |4 edt | |
| 700 | 1 | |a Nakamura, Hiroyuki |e herausgeberin |4 edt | |
| 700 | 1 | |a Aoshiba, Kazutetsu |e herausgeberin |4 edt | |
| 776 | 1 | |z 9789811044656 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-981-10-4465-6 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-10-4466-3 |m B:SPRINGER |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 2 | |u https://swbplus.bsz-bw.de/bsz49503519xcov.jpg |m V:DE-576 |m X:springer |q image/jpeg |v 20180123123525 |3 Cover |
| 889 | |w (DE-627)1002534992 | ||
| 912 | |a ZDB-2-SEB | ||
| 912 | |a ZDB-2-SME |b 2018 | ||
| 912 | |a ZDB-2-SXM |b 2018 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a ISIL_DE-Ma9 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a ISIL_DE-Ma14 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a ISIL_DE-14 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.2 | ||
| 980 | |2 22 |1 01 |x 0018 |b 1736647105 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 24-12-17 | ||
| 980 | |2 65 |1 01 |x 0003/5555 |b 1831176904 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-SME |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 08-12-18 | ||
| 980 | |2 100 |1 01 |x 3100 |b 1845778294 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 28-01-19 | ||
| 980 | |2 101 |1 01 |x 3101 |b 1845871804 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 28-01-19 | ||
| 980 | |2 120 |1 01 |x 0715 |b 174806021X |h OLR-ESP |k Campusweiter Zugriff (Universität Oldenburg). - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden. |y z |z 05-02-18 | ||
| 980 | |2 120 |1 02 |x 0715 |b 3936783926 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |k ww |y z |z 11-06-21 | ||
| 980 | |2 2006 |1 01 |x DE-14 |b 3389889078 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 15-02-18 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 3389889132 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 17-10-17 | ||
| 981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 65 |1 01 |x 0003/5555 |y Volltextzugang Campus |r https://doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 100 |1 01 |x 3100 |r https://doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 100 |1 01 |x 3100 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-Medicine-einzeln/doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 101 |1 01 |x 3101 |r https://doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 101 |1 01 |x 3101 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-Medicine-einzeln/doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 120 |1 01 |x 0715 |r https://doi.org/10.1007/978-981-10-4466-3 | ||
| 981 | |2 120 |1 02 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991015259009403501 | ||
| 981 | |2 2006 |1 01 |x DE-14 |r http://dx.doi.org/10.1007/978-981-10-4466-3 | ||
| 983 | |2 120 |1 00 |x DE-715 |8 99 |a ww | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 120 |1 01 |x 0715 |a YH 2021 | ||
| 995 | |2 65 |1 01 |x 0003/5555 |a OLR-SEB-ZDB-2-SME | ||
| 995 | |2 100 |1 01 |x 3100 |a OLR-SEB | ||
| 995 | |2 101 |1 01 |x 3101 |a OLR-SEB | ||
| 995 | |2 120 |1 01 |x 0715 |a OLR-ESP | ||
| 995 | |2 120 |1 02 |x 0715 |a alma | ||